...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Amgen cholesterol drug Repatha "Profound Regression", Dr. Nissen

Golfyeti,

Thanks for sharing. Sounds like these LDL-lowering anti-PCSK9 antibody therapies are doing quite well in the clinic. Lower LDL dramatically? Check. Decrease plaque volume? Check. Now we wait until early 2017 for the cardiovascular outcomes trial data. However, the big elephant in the room is the price tag.

BearDownAZ

Share
New Message
Please login to post a reply